- Home
- CGEM vs NGS Comparison
CGEM vs NGS Comparison
Compare CGEM & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- NGS
- Stock Information
- Founded
- CGEM 2016
- NGS 1998
- Country
- CGEM United States
- NGS United States
- Employees
- CGEM N/A
- NGS N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- NGS Oilfield Services/Equipment
- Sector
- CGEM Health Care
- NGS Energy
- Exchange
- CGEM Nasdaq
- NGS Nasdaq
- Market Cap
- CGEM 366.3M
- NGS 305.2M
- IPO Year
- CGEM 2021
- NGS 2002
- Fundamental
- Price
- CGEM $5.95
- NGS $27.14
- Analyst Decision
- CGEM Strong Buy
- NGS Strong Buy
- Analyst Count
- CGEM 7
- NGS 3
- Target Price
- CGEM $26.00
- NGS $33.67
- AVG Volume (30 Days)
- CGEM 789.8K
- NGS 63.6K
- Earning Date
- CGEM 11-06-2025
- NGS 11-13-2025
- Dividend Yield
- CGEM N/A
- NGS 1.49%
- EPS Growth
- CGEM N/A
- NGS 33.85
- EPS
- CGEM N/A
- NGS 1.42
- Revenue
- CGEM N/A
- NGS $164,109,000.00
- Revenue This Year
- CGEM N/A
- NGS $9.86
- Revenue Next Year
- CGEM N/A
- NGS $14.21
- P/E Ratio
- CGEM N/A
- NGS $18.95
- Revenue Growth
- CGEM N/A
- NGS 14.77
- 52 Week Low
- CGEM $5.68
- NGS $16.73
- 52 Week High
- CGEM $17.98
- NGS $29.74
- Technical
- Relative Strength Index (RSI)
- CGEM 39.45
- NGS 49.35
- Support Level
- CGEM $5.68
- NGS $26.50
- Resistance Level
- CGEM $6.13
- NGS $28.44
- Average True Range (ATR)
- CGEM 0.29
- NGS 0.79
- MACD
- CGEM 0.03
- NGS -0.18
- Stochastic Oscillator
- CGEM 28.42
- NGS 22.32
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.